Biotech | May 01, 2022
Inmagene receives USFDA's IND clearance for ox40 antagonist
The planned Phase 1 study is a double-blind, randomized, placebo-controlled dose-escalation study in healthy adult subjects and AD patients
The planned Phase 1 study is a double-blind, randomized, placebo-controlled dose-escalation study in healthy adult subjects and AD patients
It affects up to 10 per cent of women of reproductive age around the world
The plant is expected to start commercial operations from Q4FY24
Submission to regulators globally is based on phase 2/3 studies of mRNA-1273 in young children
For over a decade, AstraZeneca and Plan India’s Young Health Program have been generating awareness and identifying sustainable solutions to influence the behaviour of youths against Non-Communicable Diseases
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
The procedure, named 'Shetty Test' after its creator, could change the way suspected fractures are treated
This facility will design & develop instruments, perform product reliability performance testing and verification
Tembo and UFlex-Asepto have co-developed 100% renewable and recyclable paper straw solution that will be food grade, moisture-resistant and made from sustainably sourced papers
Beyond the technical leadership from F1, the collaboration will bring a specific focus on the people dimension of high performance
Subscribe To Our Newsletter & Stay Updated
